Sponsor or institution

Clinical trials and research at SCRI Development Innovations, LLC

• 5Clinical trials
• 1Country

Newest trials

All recruiting trials (5)

• Elranatamab given as outpatient in relapsed or refractory multiple myeloma

  This study tests a bispecific antibody called elranatamab, given in an outpatient setting to adults with relapsed or refractory multiple myeloma who have had prior therapies.

  Recruiting at 6 sites Phase 2 SCRI Development Innovations, LLC · Denver, Colorado and 5 other locations · NCT07637578

• Fruquintinib plus FOLFIRI for second-line metastatic colorectal cancer

  This study will test whether adding fruquintinib to FOLFIRI helps people with metastatic colorectal cancer who progressed after first-line FOLFOX plus bevacizumab.

  Recruiting at 14 sites Phase 2 SCRI Development Innovations, LLC · Denver, Colorado and 13 other locations · NCT07011576

• Frontline T-cell engager plus daratumumab versus autologous stem cell transplant with MRD-guided intensification for newly diagnosed multiple myeloma

  This trial tests whether a BCMA-directed T-cell engager (elranatamab) combined with daratumumab can replace autologous stem cell transplant and use MRD results to guide later intensification in adults with newly diagnosed multiple myeloma who already completed standard induction therapy.

  Recruiting at 10 sites Phase 2 SCRI Development Innovations, LLC · Birmingham, Alabama and 10 other locations · NCT06974786

• Outpatient treatment for multiple myeloma using teclistamab or talquetamab

  This study is testing if two new treatments, teclistamab and talquetamab, can safely help adults with relapsed or hard-to-treat multiple myeloma when given as outpatient care.

  Recruiting at 16 sites Phase 2 SCRI Development Innovations, LLC · Tucson, Arizona and 16 other locations · NCT05972135

• Combining tucatinib and Doxil for HER2 positive metastatic breast cancer

  This study is testing if combining tucatinib with Doxil can help people with HER2 positive metastatic breast cancer who have already tried other treatments.

  Recruiting at 7 sites Phase 2 SCRI Development Innovations, LLC · Columbia, Maryland and 7 other locations · NCT05748834

Quick answers

How many clinical trials run by SCRI Development Innovations, LLC are recruiting right now?

5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 5. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →